Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on AusCann.
RELATED STOCKHEAD STORIES
News
Market highlights and 5 ASX small caps to watch on Friday
News
Last Orders: Small caps left behind as blue chips gain
Health & Biotech
Here’s why cannabis M&A activity is on the rise and only just getting started in Australia
News
Last Orders: The ASX saw the best IPO of 2021 so far today; but falls 0.73 per cent
Health & Biotech
Your ultimate guide to ASX pet stocks
News
Last Orders: What you might have missed on the ASX today
News
10 at 10: These ASX stocks have hit the trail this morning
News
Rise & Shine: What you need to know before the ASX opens
Health & Biotech
Pot Stocks: Althea tops the podium after becoming a licensed producer
Health & Biotech
Pot stocks look to launch new products following yesterday’s TGA ruling
Health & Biotech
COVID-19 hasn’t hurt cannabis clinical trials … much
News
North American pot stocks are on fire, Aussies still MIA
Health & Biotech
Pharmaxis forges ahead with phase 2 cancer drug trial in spite of COVID-19
Health & Biotech
Will COVID-19 impact pot stocks? Depends on what part of the industry you’re in
News
Weed Week: Cannabis tourists are officially testing Amsterdam’s patience
News
Cannabis: AusCann on track to deliver new cannabinoid capsules by mid-year
Food & Agriculture
